OXT and Prader-Willi syndrome: The most clinically tested biomolecule is oxytocin, currently in a Phase 4 study for the indication of autism spectrum disorder and schizophrenia, in Phase 3 for the treatment of Prader-Willi syndrome (PWS) and in Phase 2 for the treatment of dementia and obesity.